Dark

CANF
Can-Fite Biopharma Ltd - ADR
stock NYSEAMERICAN ADR

Market Open

5/30/2023 12:35:30 PM EDT

2.43USD+8.482%(+0.19)0

1.93Bid 2.98Ask 1.05Spread IEX

Pre-market

5/30/2023 8:00:30 AM EDT

2.50USD+11.607%(+0.26)0

After-hours

5/2/2023 4:03:30 PM EDT

2.01USD+0.500%(+0.01)0

Overview HistoricalMore

open chart

Market Cap

3.746M

CEO

Pnina Fishman

Headquarters

P O Box 7537, Petah Tikva, Israel

Industry

Biotechnology

Last Split

2023-01-091for10reverse

MNTA MLNT XLV

CANF Stats

Avg. Vol. 10 Day

22,811

Avg. Vol. 30 Day

61,718

Market Cap

3,745,597

Shares Out.

1,541,398

On/Off Exchange

45%/55%

6 Month Beta

0.62

1 Year Beta

0.61

2 Year Beta

0.45

3 Year Beta

0.49

52 Week Low

1.52

52 Week High

11.20

SMA50

1.98

SMA200

4.29

1 Week

+2.53%

1 Month

+38.86%

3 Month

-10.00%

6 Month

-71.07%

1 Year

-74.14%

2 Year

-88.59%

5 Year

-98.75%

Jan 31, 2022

07:07AM EST Can Fite Says First Patient Enrolled In Phase IIb NASH Clinical Trial With Namodenoson RTTNews

07:06AM EST Can Fite Announces First Patient Enrolled In Phase IIb NASH Clinical Trial With Namodenoson Benzinga

Jan 21, 2022

11:40AM EST CanFite Shares Quiet Following US National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis' Benzinga

Jan 14, 2022

04:48PM EST Can-Fite Files For Offering Of Up To 190.5M Shares Benzinga

Jan 13, 2022

11:47AM EST The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact Benzinga

More News

Profile

Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.

CANF Stock Summary

Can-Fite Biopharma Ltd - ADR (NYSEAMERICAN:CANF) stock price today is $2.43, and today's volume is 0. CANF is up 8.482% today. The 30 day average volume is 61,718. CANF market cap is 3.746M with 1,541,398 shares outstanding.